PicoCELA EBIT

The latest EBIT for PCLA is $-3.2B as of March 2026. That compares with $-450M in the prior-year period — down 611.2% year over year. That is below the sector sector average of $2.5T. Investors often review this figure alongside PicoCELA's historical trend and sector peers before judging valuation or financial health.

Over the past year, PCLA's EBIT moved from $-450M to $-3.2B — a 611.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PicoCELA's operating scale or balance-sheet position.

Against its sector companies, PCLA currently prints $-3.2B for EBIT, while the sector average sits near $2.5T. That is roughly 100.1% below the sector mean. Large gaps often invite a closer look at PicoCELA's growth, margins, and balance sheet.

A EBIT figure of $-3.2B for PCLA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.5T. Explore the charts below for those layers of context.

After noting PCLA's EBIT ($-3.2B), review year-over-year change from $-450M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.